Sandy Draper
Stock Analyst at Guggenheim
(3.57)
# 892
Out of 4,735 analysts
125
Total ratings
56%
Success rate
17.98%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $347.52 | +24.31% | 12 | Jul 24, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $6 | $6.88 | -12.79% | 5 | Jun 28, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $205.69 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $169.81 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $10.17 | +234.32% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.71 | +112.31% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $55.52 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.60 | +234.28% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $205.07 | +28.25% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $3.41 | +779.77% | 3 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $94 | $104.74 | -10.25% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $9.50 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $22.73 | +124.37% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $167.46 | -22.97% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $43.60 | +26.15% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $54.26 | +209.62% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $29.81 | -59.75% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.49 | +36,627.20% | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $22.09 | +72.02% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.55 | +800.90% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $14.18 | +358.39% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $5.68 | +533.80% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $223.04 | -25.13% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.73 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $16.67 | +277.92% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $347.52
Upside: +24.31%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $6.88
Upside: -12.79%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $205.69
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $169.81
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $10.17
Upside: +234.32%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.71
Upside: +112.31%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $55.52
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.60
Upside: +234.28%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $205.07
Upside: +28.25%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $3.41
Upside: +779.77%
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $104.74
Upside: -10.25%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $9.50
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $22.73
Upside: +124.37%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $167.46
Upside: -22.97%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $43.60
Upside: +26.15%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $54.26
Upside: +209.62%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $29.81
Upside: -59.75%
Mar 29, 2021
Initiates: Buy
Price Target: $180
Current: $0.49
Upside: +36,627.20%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $22.09
Upside: +72.02%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $5.55
Upside: +800.90%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $14.18
Upside: +358.39%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $5.68
Upside: +533.80%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $223.04
Upside: -25.13%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.73
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $16.67
Upside: +277.92%